Vicapsys Life Sciences Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 2

Employees

  • Stock Symbol
  • VICP

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.50
  • (As of Wednesday Closing)

Vicapsys Life Sciences General Information

Description

Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.

Contact Information

Formerly Known As
SSGI, Phage Therapeutics International
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 7778 Mcginnis Ferry Road
  • Suite 270
  • Suwanee, GA 30024
  • United States
+1 (972)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Distributors (Healthcare)
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 7778 Mcginnis Ferry Road
  • Suite 270
  • Suwanee, GA 30024
  • United States
+1 (972)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vicapsys Life Sciences Stock Performance

As of 04-Nov-2026, Vicapsys Life Sciences’s stock price is $0.50. Its current market cap is $16.2M with 32.4M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.50 $0.50 $0.10 - $1.75 $16.2M 32.4M 3.87K

Vicapsys Life Sciences Financials Summary

As of 30-Sep-2024, Vicapsys Life Sciences has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 224,753 88,129 34,849
Revenue 0 0 0 0
EBITDA (1,257) (1,162) (954) (206)
Net Income (1,347) (1,182) (985) (237)
Total Assets 90 40 72 594
Total Debt 579 354 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vicapsys Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vicapsys Life Sciences‘s full profile, request access.

Request a free trial

Vicapsys Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vicapsys Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vicapsys Life Sciences‘s full profile, request access.

Request a free trial

Vicapsys Life Sciences Acquisitions (2)

Vicapsys Life Sciences’s most recent deal was a Merger/Acquisition with Surge Solutions Group. The deal was made on 26-Dec-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Surge Solutions Group 26-Dec-2017 Merger/Acquisition Environmental Services (B2B)
B&M Construction 18-May-2010 Merger/Acquisition Construction and Engineering
To view Vicapsys Life Sciences’s complete acquisitions history, request access »

Vicapsys Life Sciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Vicapsys Life Sciences’s complete esg history, request access »

Vicapsys Life Sciences FAQs

  • When was Vicapsys Life Sciences founded?

    Vicapsys Life Sciences was founded in 1996.

  • Where is Vicapsys Life Sciences headquartered?

    Vicapsys Life Sciences is headquartered in Suwanee, GA.

  • What is the size of Vicapsys Life Sciences?

    Vicapsys Life Sciences has 2 total employees.

  • What industry is Vicapsys Life Sciences in?

    Vicapsys Life Sciences’s primary industry is Biotechnology.

  • Is Vicapsys Life Sciences a private or public company?

    Vicapsys Life Sciences is a Public company.

  • What is Vicapsys Life Sciences’s stock symbol?

    The ticker symbol for Vicapsys Life Sciences is VICP.

  • What is the current stock price of Vicapsys Life Sciences?

    As of 04-Nov-2026 the stock price of Vicapsys Life Sciences is $0.50.

  • What is the current market cap of Vicapsys Life Sciences?

    The current market capitalization of Vicapsys Life Sciences is $16.2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process